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Supplemental Figure Legend  
 
Figure S1: related to all main figures.  
(A) Schematic of a fiber photometry setup. See Supplementary Experimental Procedures for 
details.  
(B) Representative trace from a DRNDA-GCaMP6f mouse that shows dynamic Ca2+-dependent 
fluorescence across time.  
(C) Representative trace from a DRNDA-eGFP mouse. Notice minimal fluctuations in fluorescence.  
(D) Confocal image of serotonin (5-HT, green) and dopamine (TH, red) neurons in the DRN. 
Notice that there is no overlap between the two populations and that the number of TH+ 
neurons is far less than that of 5-HT+ neurons. Scale bar is 100 µm.  
(E) Viral expression of diverse transgenes did not affect normal sleep-wake architecture both in 
light (left) and dark (right) phases (n = 4 per group; one-way ANOVA, all p > 0.2).  
(F) Time spent in each state per hour in 24-hour recordings: Wake (left), NREM (middle), and 
REM sleep (right).  
(G) Representative confocal image of GCaMP6f+ neurons in the DRN and the location of fiber-
tip (in this case, for fiber photometry). Scale bar is 100 µm.  
(H) Histologically verified fiber-tip locations of DRNDA-GCaMP6f (dark blue), DRNDA-GCaMP6s (green), 
DRNDA-ChR2 (sky blue), DRNDA-eGFP (orange), and DRNDA-Arch (yellow) mice.  
Data are represented as mean ± s.e.m. 
 
Figure S2: related to Figure 1.  
(A) Left, social interaction between a male DRNDA-GCaMP6f resident mouse and a male juvenile 
intruder were associated with increased DRNDA activity. Right, quantification of the area under 
the curve per second (AUC) showed that DRNDA activity during first interaction (0 – 5 s) was 
significantly increased compared with baseline (-5 – 0 s) (n = 7 DRNDA-GCaMP6f mice, paired t-test, 
t6 = 4.679, **p < 0.01).  
(B) Left, attack/fight bouts (first bout only) between a male DRNDA-GCaMP6f resident and an adult 
intruder were associated with increased DRNDA activity. Right, DRNDA activity during attack (0 – 
5 s) was significantly increased relative to baseline (-5 – 0 s) (n = 4 DRNDA-GCaMP6f mice, paired t-
test, t3 = 4.993, *p < 0.05).  
(C) Left, brief air puffs (<1 s) were intermittently delivered to the tail of a DRNDA-GCAMP6f mouse, 
which caused time-locked DRNDA fluorescence increase. Right, DRNDA activity after air puff 
delivery (0 – 5 s) was significantly increased relative to baseline (-5 – 0 s) (n = 7 DRNDA-GCaMP6f 
mice; paired t-test, t6 = 7.518, ***p < 0.001).  
(D) Left, fiber photometry recording of DRNDA-GCaMP6f mice undergoing a 5-minute tail 
suspension test. DRNDA neurons showed time-locked activation at the onset of mobility or 
struggling. Right, AUC values during mobility (0 – 5 s) were significantly increased compared 
with baseline (-5 – 0 s) (n = 7 DRNDA-GCaMP6f mice, paired t-test, t6 = 3.044, *p < 0.05).  
(E) Left, investigation of predator odor TMT was associated with increase in DRNDA activity. 
Right, quantification of the AUC showed that there was significant difference in DRNDA activity 
between interaction (0 – 5 s) and baseline (-5 – 0 s) (n = 7 DRNDA-GCaMP6f mice, paired t-test, t6 = 
2.653, *p < 0.05).  
(F) Left, there was a prolonged increase in DRNDA neuronal activity while a DRNDA-GCaMP6f 
mouse was restrained or immobilized. Right, sustained activation of DRNDA neurons was 
observed throughout the restraint period (0 – 60 s), compared baseline (-60 – 0 s) (n = 6 DRNDA-
GCaMP6f mice, paired t-test, t5 = 5.444, **p < 0.01).  
(G) Left, averaged DRNDA activity was increased during second and third interaction bouts (red 
trace), when a resident male DRNDA-GCaMP6f mouse was investigating a female intruder. 
Photometry data from first interaction (black trace, Fig 1D) was also illustrated for comparison. 
Right, AUC values during second and third interaction bouts (0 – 5 s) were significantly 
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increased relative to baseline (-5 – 0 s) (n = 7 DRNDA-GCaMP6f mice, paired t-test, t6 = 4.437, **p < 
0.01).  
(H) Left, averaged DRNDA activity was increased during the second and third episodes of 
aggression (red trace) by a resident male DRNDA-GCaMP6f mouse against a male intruder. 
Photometry data from the first attack episode (black trace, Fig. S2B) was also illustrated for 
comparison. Right, quantification of AUC revealed that DRNDA activity during the second and 
third episodes of attack (0 – 5 s) was significantly increased relative to baseline (-5 – 0 s) (n = 4 
DRNDA-GCaMP6f mice, paired t-test, t3 = 3.235, *p < 0.05).  
(I) Left, averaged DRNDA activity during the second and third investigation bouts (red trace) in 
novel object interaction assays was not different from preceding baseline. Photometry data from 
first interaction bout (black trace, Fig. 1J) was also illustrated for comparison. Right, 
quantification of the area under the curve per second (AUC) showed that DRNDA activity during 
the second and third interactions with a novel object (0 – 5 s) was not significantly increased 
compared with baseline (-5 – 0 s) (n = 7 DRNDA-GCaMP6f mice, paired t-test, t6 = 2.406, p > 0.05).  
(J) Left, a robust increase in DRNDA activity during the first interaction bout with a female mouse 
was observed in both single-housed (black, Fig. 1D) and group-housed (purple) mice. Right, 
quantification of AUC values during interaction (0 – 5 s) from single-housed and group-housed 
mice showed that there was no significant difference in DRNDA activity based on housing 
conditions (n = 7 single-housed, n = 4 group-housed DRNDA-GCaMP6f mice; unpaired t-test, p > 
0.1).  
(K) Left, time-locked DRNDA activation was present when single-housed (black, Fig. 1H) and 
group-housed (purple) mice received unexpected electric footshocks. Right, AUC values during 
footshock delivery did not differ between single- and group-housed mice (n = 7 single-housed, n 
= 4 group-housed DRNDA-GCaMP6f mice; unpaired t-test, p > 0.7).  
(L) Left, small DRNDA activation was observed in the first interaction bout with a novel object in 
both single-housed (black, Fig. 1J) and group-housed (purple) mice. Right, AUC values during 
novel object interaction were not distinct between single- and group-housed mice (n = 7 single-
housed, n = 4 group-housed DRNDA-GCaMP6f mice; unpaired t-test, p > 0.5).  
(M) Representative fiber photometry recording (black: fluorescence trace) and real-time 
locomotion tracking (red: velocity) for a DRNDA-GCaMP6f mouse during the open field test. Notice 
the lack of temporal correlation between two signals. 
(N) Averaged velocities aligned by detected Ca2+ peak event onset showed that increased 
DRNDA activity is not associated with any change in velocity.  
(O) Averaged DRNDA activity aligned by detected locomotion onset revealed that locomotion 
onset (indexed by increase of velocity) was not associated with a change in DRNDA 
fluorescence.  
Data are represented as mean ± s.e.m. 
 
Figure S3: related to Figure 2 and 3.  
(A) Representative example of a REM-to-wake transition from a DRNDA-GCaMP6s mouse with EEG 
spectrogram, EEG, EMG, and fiber photometry traces. Note that DRNDA fluorescence was 
increased at the wake onset, when EEG shifted from theta oscillations (5-10 Hz) to 
desynchronized rhythms and EMG amplitude abruptly increased.  
(B) Same as (A), but from a DRNDA-eGFP mouse. No change in fiber photometry signal is 
observed.  
(C) Power spectral density plots of DRNDA-GCaMP6s mice at each state: wake (blue), NREM (red), 
and REM (green). Notice that they show normal spectral EEG characteristics at each state: 
wake is characterized by smaller low-frequency activity and elevated high-frequency activity, 
NREM is characterized by high delta or slow wave (0.5-4 Hz) activity with suppressed high-
frequency rhythms, and REM is associated with high theta (5-10 Hz) peak with elevated high-
frequency activity.  
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(D) Even with constant LED light exposure for exciting GCaMP6s, DRNDA-GCaMP6s mice showed 
normal sleep-wake architecture during light phase when synchronized photometry and 
EEG/EMG recordings were performed. Left, time spent at each state (For comparison, please 
see Fig. S1E). Right, mean duration of each state.  
(E) After aligning the linearly scaled control 405 nm signal (red) with the 490 nm signal (blue), 
no noticeable decay was detected in the quality or signal-to-noise ratio of an extended 
photometry trace (black, 12-hour recording).  
(F) A representative photometry recording from a DRNDA-GCaMP6s mouse, with examples of 
automatically detected Ca2+ peak events (red). Detection onsets are denoted with black 
asterisks.  
(G) The frequency of detected peak events per 5-second window did not vary across sleep-
wake states (n = 6 DRNDA-GCaMP6s mice; one-way ANOVA, F2,15 = 0.07802,  p > 0.9).  
(H) Duration of the detected peak events did not vary significantly across sleep-wake states (n = 
6 DRNDA-GCaMP6s mice; one-way ANOVA, F2,15 = 0.2999,  p > 0.7).   
(I) Amplitude (z-scored) of the detected peak events was significantly increased in wake 
compared to NREM sleep (n = 6 DRNDA-GCaMP6s mice; one-way ANOVA, F2,15 = 7.144,  p < 0.01; 
Post-hoc Bonferroni Analysis, **p < 0.01)  
(J) Summed area under curve values within a 5-sec window was significantly increased at wake 
state over NREM and REM sleep (n = 6 DRNDA-GCaMP6s mice; one-way ANOVA, F2,15 = 15.59, p 
< 0.001; Post-hoc Bonferroni Analysis, **p < 0.01, ***p < 0.001).  
(K) To additionally confirm that wake DRNDA dynamics (activity peak soon after onset and 
gradual decrease, see Figure 2H) did not originate from photo-bleaching, we only isolated the 
wake episodes whose durations were similar to NREM and REM sleep episode durations 
(between 25th and 75th percentile of the sleep duration distribution, which were 80 and 260 
seconds respectively) and plotted the normalized fluorescence over normalized time similar to 
Figure 2H. We observe the similar trend, suggesting that the observed wake dynamics is unique 
to DRNDA neurons and that the contribution from photo-bleaching is minimal.  
(L) Left, when mice made transitions from REM sleep to NREM sleep through a short period of 
arousal (wake shorter than 15 seconds), the DRNDA activity decreased. Right, Quantification of 
the area under the curve per second showed that DRNDA activity was significantly lower after 
transitions than before transitions (n = 6 DRNDA-GCaMP6s mice, paired t-test, t5 = 2.823, *p < 0.05).  
Data are represented as mean ± s.e.m. 
 
Figure S4, related to Figure 4.  
(A) Ex vivo patch clamp recording demonstrated that DRNDA neurons could faithfully follow our 
parameters of phasic stimulation (30 Hz, 10 pulses, 10 ms pulse width).  
(B) Representative EEG (black) and EMG (gray) recordings when phasic DRNDA stimulation 
caused immediate (<5 second) NREM-to-wake transitions in a DRNDA-ChR2 mouse. Notice the 
termination of slow delta waves and abrupt increase of muscle activity after a phasic pulse. The 
same phasic stimulation paradigm did not cause any state changes in a DRNDA-eGFP mouse.  
(C) Same as (B), but when phasic stimulation occurred during REM sleep.  
(D) Two-minute tonic stimulations (continuous 2 Hz pulses for 2 minutes, 10 ms pulse width) 
were delivered every 20-25 minutes to DRNDA-ChR2 and DRNDA-eGFP mice.  
(E) Tonic stimulation caused a small increase in the wake probability and a small decrease in 
the NREM and REM probability in DRNDA-ChR2 mice.  
(F) No changes were observed upon tonic stimulation in DRNDA-eGFP mice.  
(G) REM state probability was significantly decreased in DRNDA-ChR2 mice compared to DRNDA-
eGFP mice (n = 8 DRNDA-ChR2 mice, n = 7 DRNDA-eGFP mice; unpaired t-test, *p < 0.05). Although 
DRNDA-ChR2 mice appeared to spend more time in the wake state, this trend did not reach 
statistical significance (unpaired t-test, p = 0.057). There were no significant differences in 
NREM state probability change between two groups (unpaired t-test, p > 0.3).  
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(H) Power spectral density of DRNDA-ChR2 mice (see Figure 4H), but divided into low (0.5-30 Hz) 
and high (40-100 Hz) frequency ranges for better visualization.  
(I) Same as (H), but for power spectral density of DRNDA-eGFP mice (see Figure 4I). 
(J) Wake-promoting effect of DRNDA activation was abolished with systemic administration of D1 
and D2 receptor antagonists. D1/D2 antagonists injection resulted in a significant decrease of 
the time spent awake (n = 4 DRNDA-ChR2 mice; paired t-test, t3 = 7.161, **p<0.01) and a 
significant increase in the time spent in NREM (paired t-test, t3 = 5.796, *p<0.05) and REM 
sleep (paired t-test, t3 = 6.673, **p<0.01), compared to saline injection.  
(K) DRNDA-eGFP mice showed no significant change in the time spent in any state (n = 4 DRNDA-
eGFP mice, paired t-test, all p>0.4) after systemic administration of saline or D1/D2 antagonists.  
(L) DRNDA-ChR2 and DRNDA-eGFP mice underwent the open field test at the dark and light phases 
to examine the causal effect of DRNDA activation with locomotion. There was no difference in 
distance traveled in the open field between the two mouse groups across light OFF and ON 
epochs in both phases(n = 6 per group; two-way ANOVA revealed no light x epoch interaction in 
both phases, F2,20 (dark) = 0.089, p > 0.9, F2,20 (light) = 2.088, p > 0.1).  
(M) Real-time place preference/aversion assay with DRNDA-ChR2 and DRNDA-eGFP mice 
demonstrated that DRNDA-ChR2 mice spent less time in the chamber paired with phasic light 
stimulation, but this trend for place aversion was not statistically different from DRNDA-eGFP mice 
group place preference/aversion (n = 6 per group; unpaired t-test, p > 0.1).  
(N) Virus injection into the DRN results in the transgene expression in the caudal linear nucleus 
(CLi) but not in the retrotrubral field (RRF). Scale bar is 1 mm.  
(O) Virus injection into the DRN does not result in cell-body expression, but show fibers 
(originating from DRN) in the VTA or SNc. Scale bar is 1 mm.  
(P) ChR2-eYFP fibers were found in the basolateral amygdala (BLA) and the central nucleus of 
the amygdala (CeA).  
(Q) Bed nucleus of the stria terminalis (BNST).  
(R) Caudal part of nucleus accumbens (NAc).  
(S) Medial prefrontal cortex (mPFC). All scale bars from (P) to (S) are 500 µm.  
Data are represented as mean ± s.e.m. 
 
Figure S5, related to Figure 5.  
(A) Images of DIC (upper) and fluorescence (lower) from a patched DRNDA neuron expressing 
hM4Di-mCherry.  
(B) Representative example recording of membrane potentials from an hM4Di+ DRNDA neuron. 
Bath application of CNO (1 uM) resulted in hyperpolarization and a reduction of neuronal firing, 
which was recovered after washout. Holding potential was at -45 mV. 
(C) Same as (B), but for an eGFP+ DRNDA neuron. Notice that there was no detectable change 
in membrane potential or firing rate. Holding potential was at -45 mV.  
(D) Application of CNO reduced the membrane potential of hM4Di+ neurons, but not in eGFP+ 
neurons. (n = 4 cells each; unpaired t-test, *p < 0.05). Baseline was defined as 1-minute epoch 
before CNO application, and CNO induced change was quantified from 2 to 4 minutes after 
CNO bath application.  
(E) Firing rate was significantly reduced with CNO application in hM4Di+ neurons, relative to 
eGFP+ neurons (n = 4 cells each; unpaired t-test, **p < 0.01).    
(F-I) Stereotaxic injection of AAV2-hSyn-DIO-hM4Di-mCherry (red) vectors into the DRN of TH-
Cre mice did not result in anterograde or retrograde transport to other TH+ neurons (green) in 
(F) locus coeruleus (LC), (G) retrorubral field (RRF), (H) ventral tegmental area (VTA), and (I) 
substantia nigra pars compacta (SNc) after one month. Axonal fibers (presumably coming from 
the DRNDA neurons) were shown, but no cell body expression was present in these areas. Scale 
bars are 100 um.  
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(J) Power spectral density during wakefulness from DRNDA-hM4Di mice after saline (blue) and 
CNO (red) injection. Notice that EEG spectra after CNO delivery were not distinct from saline 
controls.  
(K) Same as (J), but for NREM sleep.  
(L) Same as (J), but for REM sleep.  
Data are represented as mean ± s.e.m. 
 
Figure S6, related to Figure 6.  
(A) Fiber photometry and EEG/EMG recordings were performed in DRNDA-GCaMP6s mice. 
Arousing auditory tones (65 dB, 2-5 kHz, 2 Hz pulse frequency, 250 ms pulse, for 10 seconds) 
were randomly triggered during the light phase. 
(B) The presentation of auditory cues was associated with a time-locked increase in DRNDA 
activity, especially in sleep-to-wake transitions. 
(C) DRNDA activity change, as indexed by the difference in the area under the curve between 
before (-30-0 s) and after (0-30 s) tone presentation, was larger when the auditory tone induced 
sleep-to-wake transitions (within 10 seconds) than when it was turned on during the wake state 
or when it failed to cause sleep-to-wake transitions (n = 7 DRNDA-GCaMP6s mice; one-way ANOVA, 
F2,18 = 10.79, p < 0.001, Bonferroni post-hoc analysis, *p < 0.05, ***p < 0.001). 
(D) Increased DRNDA population activity was observed when arousing tones woke up DRNDA-
GCaMP6s mice from NREM (red) or REM (green) sleep states.   
(E) The time-locked increase in DRNDA activity upon auditory tone presentation did not vary 
according to the type of sleep-to-wake transitions (NREM-to-wake versus REM-to wake; n = 7 
DRNDA-GCaMP6s mice, paired t-test, t6 = 1.4094, p > 0.2).  
(F) EEG/EMG monitoring was performed with DRNDA-Arch or DRNDA-hM4Di mice while auditory 
tones (70 dB) were turned on during the light phase. Green laser (532 nm) was applied for 20 
seconds surrounding the tonal stimuli for time-locked DRNDA inhibition. 
(G) Confocal images of Arch+ (green) neurons co-localized with TH (red) expression. Scale bar 
is 100 µm.  
(H) There was a noticeable decrease in delta (0.5-4 Hz) amplitude in NREM-to-wake trials 
(blue), when auditory cues successfully caused wake transitions from NREM sleep, whereas 
there was minimal change of delta (0.5-4 Hz) amplitude in NREM-to-NREM trials (red), when 
auditory cues failed to cause wake transitions from NREM. Data are pooled together from both 
DRNDA-Arch and DRNDA-eGFP mice. 
(I) There was no difference in delta (0.5-4 Hz) amplitude before and after tones in NREM-to-
NREM trials (n = 67 trials; paired t-test, t66 = 1.310, p > 0.1). However, there was significant 
decrease in delta (0.5-4 Hz) amplitude across tones in NREM-to-wake trials (n = 123 trials; 
paired t-test, t122 = 10.58, ***p < 0.0001). 
(J) There was a noticeable decrease in theta (5-10 Hz) amplitude in REM-to-wake trials (blue), 
when auditory cues successfully caused wake transitions from REM sleep, while there was 
minimal change of theta (5-10 Hz) amplitude in REM-to-REM trials (red), when auditory cues 
failed to cause wake transitions from REM trials. Data are pooled together from both DRNDA-Arch 
and DRNDA-eGFP mice. 
(K) There was no difference in theta (5-10 Hz) amplitude before and after tones in REM-to-REM 
trials (n = 5 trials; paired t-test, t4 = 0.2832, p > 0.7). However, there was significant decrease in 
theta amplitude across tones in REM-to-wake trials (n = 30 trials; paired t-test, t29 = 5.786, ***p < 
0.0001). 
(L) The probability of NREM-to-wake transitions upon auditory tones was significantly lower in 
DRNDA-Arch mice compared to DRNDA-eGFP mice (n = 6 DRNDA-Arch mice, n = 4 DRNDA-eGFP mice; 
unpaired t-test, p < 0.001).  
(M) Left, delta (0.5-4 Hz) amplitude decrease was less prominent in DRNDA-Arch mice compared 
to control mice. Right, delta (0.5-4 Hz) amplitude during the tone was significantly higher in 
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DRNDA-Arch mice than DRNDA-eGFP controls (n = 6 DRNDA-Arch mice, n = 4 DRNDA-eGFP mice; 
unpaired t-test, *p < 0.05). 
(N) The probability of REM-to-wake transitions upon auditory tones presentation was not 
different between DRNDA-Arch and DRNDA-eGFP mice (n = 6 DRNDA-Arch mice, n = 4 DRNDA-eGFP 
mice; unpaired t-test, p > 0.1). 
(O) Left, the decrease in theta (5-10 Hz) amplitude was similar between DRNDA-Arch and  DRNDA-
eGFP mice. Right, there was no statistically detectable difference in the theta (5-10 Hz) amplitude 
between groups during the tone presentation (n = 6 DRNDA-Arch mice, n = 4 DRNDA-eGFP mice; 
unpaired t-test, p > 0.6). 
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